Abstract:CD133 is a useful putative marker of cancer stem cells (CSCs) in human laryngeal tumors. Numerous studies have demonstrated that CD133(+) CSCs possess higher clonogenicity, invasiveness and tumorigenesis compared with CD133(-) cells. Recently, interest in the Warburg effect in the microenvironment of CSCs has escalated. The Warburg effect dictates that cancer cells rely on glycolysis rather than oxidative phosphorylation under aerobic conditions. In numerous cancer cells, glucose is used mainly for the glycolytic pathway. Stem cells express high levels of glycolytic enzymes and rely mostly on glycolysis to meet their energy demands. Glucose is transported through cell membranes by glucose transporters (Glut). Studies of Glut-1 expression in CSCs are limited. In the present study, we investigated the proliferation of CD133(+) Hep-2 cells and whether Glut-1 is expressed in laryngeal carcinoma CD133(+) Hep-2 cells. Real-time reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that the size of the CD133 product was 213 bp. Dissociation curve analysis demonstrated only the expected peaks at 82.1 degrees C for CD133. The mean Ct of CD133 expression was 10.98. Prior to isolation, the CD133(+) fraction was 1.2% by fluorescence-activated cell sorting (FACS) analysis. Following isolation, the CD133(+) fraction was increased to 76.1%. Successive tests also demonstrated that cells grew well following isolation. The proliferation of CD133(+) and CD133(-) cells was not different during the first 3 days (P>0.05). From day 4, the proliferation capacity of CD133(+) cells in vitro was higher than that of CD133(-) cells (P<0.05). The mean Ct of Glut-1 mRNA expression was 1.78 for CD133(+) cells and 1.00 for CD133(-) cells (P<0.05). The mean Glut-1 protein values in CD133(+) and CD133(-) Hep-2 cells relative to -tubulin were 0.48 +/- 0.02 and 0.21 +/- 0.03 (g/l), respectively (P<0.05). In conclusion, CD133(+) cells demonstrated higher proliferation. Glut-1 mRNA and protein levels were higher in CD133(+) than in CD133(-) cells. Our results suggest that Glut-1 is important in the energy supply of laryngeal CD133(+) Hep-2 cells and Glut-1 may represent a potential therapeutic target for the inhibition of the proliferation of laryngeal CSCs.

Effect on the Expression of MMP-2, MT-MMP in Laryngeal Carcinoma Hep-2 Cell Line by Antisense Glucose Transporter-1.

Effect Of Antisense Oligodeoxynucleotides Glucose Transporter-1 On Enhancement Of Radiosensitivity Of Laryngeal Carcinoma

Inhibition of Cell Proliferation and Glucose Uptake in Human Laryngeal Carcinoma Cells by Antisense Oligonucleotides Against Glucose Transporter‐1

Expression And Significance Of Glucose Transporter-1, P-Glycoprotein, Multidrug Resistance-Associated Protein And Glutathione S-Transferase-Pi In Laryngeal Carcinoma

Expression and Significance of Hypoxia-Inducible Factor-1Α and Glucose Transporter-1 in Laryngeal Carcinoma.

Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.

Construction and Identification of an Antisense Glucose Transporter-1 Plasmid

Relationships Between Expression of Glucose Transporter Protein-1 and Hypoxia Inducible Factor-1Α, Prognosis and 18F-FDG Uptake in Laryngeal and Hypopharyngeal Carcinomas

Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells under Hypoxic and Low-Glucose Conditions

Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.

Effects of Suppressing Glucose Transporter-1 by an Antisense Oligodeoxynucleotide on the Growth of Human Hepatocellular Carcinoma Cells

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

Decreased Mt1-Mmp in Gastric Cancer Suppressed Cell Migration and Invasion Via Regulating Mmps and Emt

Expression of Glucose Transporter in Non-Small Cell Lung Carcinoma and Its Clinical Significance

Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro.

MT1‑MMP promotes the proliferation and invasion of gastric carcinoma cells via regulating vimentin and E‑cadherin

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

Effects of Ppgalnact2 Antisense RNA on the Biological Behacior of Human Gastric Cancer SGC7901 Cell Line

Regulation of MMP-2 Expression and Activity by Β-1,3-n-acetylglucosaminyltransferase-8 in AGS Gastric Cancer Cells

Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo

MT2-MMP Expression Associates with Tumor Progression and Angiogenesis in Human Lung Cancer.